TRUIST FINANCIAL CORP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$162,000
-60.5%
1,627
-62.2%
0.00%
-100.0%
Q3 2020$410,000
-37.3%
4,299
-26.5%
0.00%0.0%
Q2 2020$654,000
+134.4%
5,852
+52.4%
0.00%0.0%
Q1 2020$279,000
-28.3%
3,841
+3.2%
0.00%0.0%
Q4 2019$389,000
+64.1%
3,723
+56.3%
0.00%
-75.0%
Q3 2019$237,000
-16.0%
2,382
-3.5%
0.00%
-20.0%
Q2 2019$282,000
-15.1%
2,468
-6.4%
0.01%
-16.7%
Q1 2019$332,000
+14.9%
2,637
+23.6%
0.01%0.0%
Q4 2018$289,000
-54.3%
2,134
-7.4%
0.01%
-45.5%
Q3 2018$632,000
+27.9%
2,305
-3.5%
0.01%
+22.2%
Q2 2018$494,000
+15.2%
2,388
-8.1%
0.01%
+12.5%
Q1 2018$429,000
+19.5%
2,599
-0.9%
0.01%
+14.3%
Q4 2017$359,000
-1.6%
2,622
-2.2%
0.01%0.0%
Q3 2017$365,000
+11.6%
2,680
-0.6%
0.01%
+16.7%
Q2 2017$327,000
+11.2%
2,696
-3.0%
0.01%0.0%
Q1 2017$294,000
-5.5%
2,779
-9.1%
0.01%0.0%
Q4 2016$311,000
-7.7%
3,058
-7.4%
0.01%
-14.3%
Q3 2016$337,000
+12.0%
3,304
+30.9%
0.01%
+16.7%
Q2 2016$301,0002,5250.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders